cAMP-CRP通过对hfqq的转录抑制来降低RNAI稳定性,促进ColE1等离子体的复制
Qi Zhou1, Na Li1, Lingling Jiao1
1College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, Zhejiang, 310014, China.
Biochemical and biophysical research communications
|September 20, 2025
概括
循环AMP受体蛋白 (cAMP-CRP) 通过减少Hfq表达来增强ColE1等离子体复制,从而稳定RNAI. 这种机制对于抗生素耐药性基因在肠道细菌中传播至关重要,突出显示了一个保存的调节轴.
科学领域:
- 微生物学 微生物学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 质粒是抗生素耐药性基因 (ARG) 的关键载体.
- 在肠杆菌中常见的COLE1型等离子体携带ARG,并依赖RNAI,RNAII和cAMP-CRP进行复制控制.
- Hfq,一个RNA伴侣,稳定RNAI以抑制复制,而cAMP-CRP抑制Hfq表达,但直接联系不清楚.
研究的目的:
- 为了阐明RNAI,RNAII和cAMP-CRP在ColE1等离子体复制中的精确相互作用.
- 通过Hfq.调查cAMP-CRP在等离子体复制中的调节作用.
- 为了确定cAMP-CRP-Hfq-RNAI调节轴是否在肠杆菌中保持.
主要方法:
- 评估不同碳来源 (葡萄糖与糖醇) 和cAMP水平下的ColE1等离子体复制.
- 分析野生型和突变菌株 (Δhfq,crp,cyaA) 的等离子体产量.
- 通过Hfq表达水平调查cAMP-CRP对RNAI稳定性的影响.
主要成果:
- 糖醇支持比葡萄糖更高的ColE1等离子体复制;cAMP的添加逆转了葡萄糖的抑制.
- cAMP-CRP刺激ColE1等离子体复制,主要通过Hfq,因为crp或cyaA的突变在Δhfq突变者中没有进一步的影响.
- cAMP-CRP抑制hfq表达,降低RNAI稳定性,从而促进等离子体复制.
- 这种cAMP-CRP-Hfq-RNAI调节机制在肠杆菌中的ColE1等离子体中得到保护.
结论:
- cAMP-CRP通过降低Hfq的调节促进ColE1等离子体的复制,导致RNAI稳定性降低.
- 这项研究揭示了Enterobacterales中等离子体复制的新型调节机制.
- 了解这种保存轴为打击抗生素耐药性基因传播提供了潜在的策略.
更多相关视频
相关概念视频
CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K
Types of RNA
9.1K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
9.1K
RNA Stability
35.6K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
35.6K
Repressible Operon: trp Operon
1.4K
The trp operon in Escherichia coli exemplifies a repressible operon. It regulates the synthesis of tryptophan through repressor-mediated transcriptional control and attenuation. This dual regulatory mechanism ensures tryptophan biosynthesis occurs only when needed, conserving cellular resources.Structure of the trp OperonThe trp operon consists of five structural genes (trpE, trpD, trpC, trpB, and trpA) that encode enzymes for tryptophan biosynthesis. These genes are transcribed as a single...
1.4K
RNA Interference
27.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.8K
Experimental RNAi
7.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.3K


